Prevention of cardiac disease in the elderly

被引:3
作者
Gladdish, S [1 ]
Rajkumar, C [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Sect Care Elderly, London W12 0NN, England
来源
JOURNAL OF CARDIOVASCULAR RISK | 2001年 / 8卷 / 05期
关键词
stroke; ageing; blood pressure; prevention; risk factors;
D O I
10.1097/00043798-200110000-00005
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
There is much evidence for identifying and altering certain risk factors, such as hypertension, diabetes, raised cholesterol levels, smoking, obesity, hormone changes and exercise to reduce the incidence of cardiovascular disease; certain drugs have also been shown to be of benefit. Although the elderly population is most likely to suffer cardiovascular disease, very little of the trial evidence has looked at this patient group. It is important that the interventions we recommend for young patients have a comparable risk/benefit profile in the elderly so that we can offer them the most appropriate treatment. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 61 条
[1]
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]
AMERY A, 1985, LANCET, V1, P1349
[3]
[Anonymous], 1980, LANCET, V1, P1261
[4]
[Anonymous], EPIDEMIOLOGY OLD AGE
[5]
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither [J].
Baigent, C ;
Collins, R ;
Appleby, P ;
Parish, S ;
Sleight, P ;
Peto, R .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7141) :1337-1343
[6]
THE HYPERTENSION IN THE VERY ELDERLY TRIAL (HYVET) - RATIONALE, METHODOLOGY AND COMPARISON WITH PREVIOUS TRIALS [J].
BULPITT, CJ ;
FLETCHER, AE ;
AMERY, A ;
COOPE, J ;
EVANS, JG ;
LIGHTOWLERS, S ;
OMALLEY, K ;
PALMER, A ;
POTTER, J ;
SEVEV, P ;
STAESSEN, J ;
SWIFT, C .
DRUGS & AGING, 1994, 5 (03) :171-183
[7]
Cigarette smoking among the elderly: Disease consequences and the benefits of cessation [J].
Burns, DM .
AMERICAN JOURNAL OF HEALTH PROMOTION, 2000, 14 (06) :357-361
[8]
Double-blind randomised trial of modest salt restriction in older people [J].
Cappuccio, FP ;
Markandu, ND ;
Carney, C ;
Sagnella, GA ;
MacGregor, GA .
LANCET, 1997, 350 (9081) :850-854
[9]
CLAUDIO B, 2001, CURR HYPERTENS REP, V3, P281
[10]
RANDOMIZED TRIAL OF TREATMENT OF HYPERTENSION IN ELDERLY PATIENTS IN PRIMARY CARE [J].
COOPE, J ;
WARRENDER, TS .
BRITISH MEDICAL JOURNAL, 1986, 293 (6555) :1145-1151